RecruitingNCT06524557
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University
Sponsor
Xijing Hospital
Enrollment
200 participants
Start Date
Jan 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
To explore an effective noninvasive method for differential diagnosis of liver tumors.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Plain Language Summary
Simplified for easier understanding
This study is using ultrasound imaging and computer analysis to develop a non-invasive way to tell the difference between benign (non-cancerous) and malignant (cancerous) liver tumors — without needing a surgical biopsy. Researchers hope this could lead to a safer, faster way to diagnose liver masses.
**You may be eligible if...**
- You are between 18 and 70 years old
- You have a liver mass that can be seen on regular ultrasound
- You are scheduled for an ultrasound-guided biopsy or surgical removal of the liver tumor
- Your imaging and pathology results will be available within 7 days of each other
**You may NOT be eligible if...**
- A clear pathological diagnosis cannot be made
- Your liver tumor is a metastasis (spread from cancer elsewhere in the body)
- Your ultrasound images are too poor in quality to analyze
- You have previously had liver surgery, radiation, chemotherapy, or a liver transplant
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTwith chronic liver disease
patients with hepatitis B virus,hepatitis C virus, or other chronic liver disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06524557